HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giulia Di Lazzaro Selected Research

early onset with mental retardation Parkinsonism

1/2021X-Linked Parkinsonism: Phenotypic and Genetic Heterogeneity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giulia Di Lazzaro Research Topics

Disease

10Parkinson Disease (Parkinson's Disease)
09/2021 - 05/2017
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2017
2Parkinsonian Disorders (Parkinsonism)
01/2022 - 01/2021
2Neuroinflammatory Diseases
10/2019 - 01/2019
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
03/2019 - 01/2018
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 12/2017
2Tauopathies
01/2018 - 01/2017
1Dyskinesias (Dyskinesia)
01/2022
1Atrophy
01/2022
1Disease Progression
09/2021
1Fragile X Tremor Ataxia Syndrome
01/2021
1early onset with mental retardation Parkinsonism
01/2021
1X-Linked Torsion Dystonia 3
01/2021
1Fabry Disease (Fabry's Disease)
01/2021
1COVID-19
06/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Autonomic Nervous System Diseases (Dysautonomia)
01/2020
1Pain (Aches)
01/2020
1Tremor (Tremors)
01/2020
1Cognitive Dysfunction
01/2020
1Nerve Degeneration
01/2019
1Restless Legs Syndrome (Restless Legs)
01/2018
1Normal Pressure Hydrocephalus
01/2018
1Frailty
01/2018
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2018
1Sialorrhea
05/2017

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2018
4Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2018
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2018
2Pharmaceutical PreparationsIBA
01/2020 - 03/2019
2Dopamine (Intropin)FDA LinkGeneric
01/2020 - 01/2019
2resolvin D1IBA
10/2019 - 01/2019
2Amyloid beta-PeptidesIBA
01/2018 - 12/2017
1IronIBA
01/2022
1Levodopa (L Dopa)FDA LinkGeneric
01/2022
1Methyl-CpG-Binding Protein 2IBA
01/2021
1EnzymesIBA
01/2020
1Glutamate-Cysteine LigaseIBA
01/2020
1Glutathione (Reduced Glutathione)IBA
01/2020
1Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
01/2020
1NeurograninIBA
01/2020
1SynucleinsIBA
01/2020
1Vitamin EFDA LinkGeneric
01/2019
1tau Proteins (tau Protein)IBA
01/2018
1Cholinergic Agents (Cholinergics)IBA
01/2018
1Dopamine Agonists (Dopamine Agonist)IBA
05/2017
1rotigotineFDA Link
05/2017
1Uric Acid (Urate)IBA
01/2017

Therapy/Procedure

5Therapeutics
09/2021 - 05/2017
1Continuity of Patient Care
06/2020
1Transcranial Direct Current Stimulation
12/2019
1Transdermal Patch
03/2019
1Complementary Therapies (Alternative Medicine)
01/2018
1Transcranial Magnetic Stimulation
01/2018